Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. | Nat Commun | 2025 | 40855071 | PubTator, text mining | PubMed |
| Identification of potential drug targets and possible drugs for esophageal carcinoma from genetic insights: a comprehensive two-sample Mendelian randomization study. | Discov Oncol | 2025 | 40853405 | PubTator, text mining | PubMed |
| Coordinated changes in midkine expression and midkine-associated multiomic profile in glioma microenvironment. | Sci Rep | 2025 | 40835683 | PubTator, text mining | PubMed |
| ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma. | Sci Rep | 2025 | 40830586 | PubTator, text mining | PubMed |
| Replication program of a single-chromosome budding yeast strain. | Nucleic Acids Res | 2025 | 40808303 | PubTator, text mining | PubMed |
| The use of urinary biomarkers as prognostic tools: predicting kidney outcomes in pediatric acute kidney injury. | Pediatr Nephrol | 2025 | 40804584 | PubTator, text mining | PubMed |
| Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis. | Sci Rep | 2025 | 40759686 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective. | Front Med (Lausanne) | 2025 | 40747097 | PubTator, text mining | PubMed |
| T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer. | J Transl Med | 2025 | 40707958 | PubTator, text mining | PubMed |
| Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection. | J Clin Invest | 2025 | 40663403 | PubTator, text mining | PubMed |
| Beyond ACEF: integrating biomarkers and intraoperative factors for enhanced AKI prediction post-SAVR. | Ren Fail | 2025 | 40620034 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing: new insights for pulmonary endothelial cells. | Front Cell Dev Biol | 2025 | 40599812 | PubTator, text mining | PubMed |
| Renal replacement therapy. | Intensive Care Med | 2025 | 40562857 | PubTator, text mining | PubMed |
| Small extracellular vesicles from human umbilical cord mesenchymal stem cells delivering miR-202-5p alleviate renal ischemia-reperfusion injury by targeting the GOLIM4/PI3K/AKT axis. | Front Immunol | 2025 | 40519909 | PubTator, text mining | PubMed |
| Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study. | Crit Care | 2025 | 40394608 | PubTator, text mining | PubMed |
| Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration. | Transl Cancer Res | 2025 | 40386252 | PubTator, text mining | PubMed |
| Selenium deficiency negatively affects survival and integrity of human hippocampal progenitor cells. | Aging Brain | 2025 | 40385247 | PubTator, text mining | PubMed |
| Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis. | Mol Cancer | 2025 | 40375239 | PubTator, text mining | PubMed |
| Spatial transcriptional landscape of human heart failure. | Eur Heart J | 2025 | 40335066 | PubTator, text mining | PubMed |
Effects of an extended therapeutic strategy versus standard-of-care therapy on persistent acute kidney injury in high-risk patients after major surgery: study protocol for the randomised controlled single-centre PrevProgAKI trial. | BMJ Open | 2025 | 40328648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=5